الرئيسية › سرطان البروستاتا › كاليفورنيا › Los Angeles
التجارب السريرية لـ سرطان البروستاتا في Los Angeles، CA
61 دراسات لـ سرطان البروستاتا تبحث عن مشاركين في مواقع داخل وحول Los Angeles (ضمن نطاق 30 ميلًا تقريبًا). افتح الدراسة لمعرفة من يمكنه المشاركة وكيفية التواصل مع فريق الدراسة.
النص الرسمي للدراسة (بالإنجليزية)
تبحث عن مشاركين لدراسة؟ أبرزها في أعلى الصفحة — $99 لمدة 30 يومًا →
High Cardiovascular Risk Intervention With Cardio-Oncology Consultation for Prostate Cancer Following Androgen Receptor Pathway Inhibitor (ARPI) Therapy (Heart-Safe)
جارٍ التسجيلالمرحلة 2
- Cedars Sinai Medical Center, Los Angeles
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
جارٍ التسجيلالمرحلة 1/2
- Research Site, Los Angeles
Study of AR Suppression With Carotuximab in Metastatic, Castration-Resistant Prostate Canc
جارٍ التسجيلالمرحلة 2
- Cedars-Sinai Medical Center, Los Angeles
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
جارٍ التسجيلالمرحلة 1
- UCLA Department of Medicine-Hematology/Oncology, Los Angeles
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
جارٍ التسجيلالمرحلة 1/2
- UCLA Jonsson Comprehensive Cancer Center, Los Angeles
- USC Norris Comprehensive Cancer Center, Los Angeles
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
جارٍ التسجيلالمرحلة 3
- Cedars-Sinai Medical Center, Los Angeles
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
جارٍ التسجيلالمرحلة 2
- Keck Medicine of USC Koreatown, Los Angeles
- Los Angeles General Medical Center, Los Angeles
- USC / Norris Comprehensive Cancer Center, Los Angeles
An Investigational Scan (Flotufolastat F 18 PET/CT) for Detecting Residual or Recurrent Disease in Patients Who Completed Focal Therapy for Prostate Cancer.
جارٍ التسجيلالمرحلة 2
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
جارٍ التسجيلالمرحلة 3
- UCLA Hematology/Oncology - Santa Monica ( Site 0044), Los Angeles
Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
جارٍ التسجيلالمرحلة 1/2
- Research Site, Los Angeles
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
جارٍ التسجيلالمرحلة 3
- Cedars-Sinai Cancer at Cedars-Sinai Medical Center, Los Angeles
- Ronald Reagan UCLA Medical Center - Drug Information Center, Los Angeles
- UCLA Department of Medicine - Hematology/Oncology, Los Angeles
- و 1 أخرى
A Study in Patients With Metastatic Castration-Resistant Prostate Cancer
جارٍ التسجيلالمرحلة 1
- START Los Angeles, Los Angeles
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
جارٍ التسجيلالمرحلة 2/3
- VA Greater LA Healthcare System, Los Angeles
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
جارٍ التسجيلالمرحلة 3
- Research Site, Los Angeles
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
جارٍ التسجيلالمرحلة 3
- Cedars-Sinai Medical Center ( Site 0068), Los Angeles
- UCLA Hematology/Oncology - Santa Monica ( Site 0002), Los Angeles
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
جارٍ التسجيلالمرحلة 3
- Urology Group of Southern California, Los Angeles
- Greater Los Angeles VA Medical Center, Los Angeles
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
جارٍ التسجيلالمرحلة 3
- Cedars-Sinai Medical Center, Los Angeles
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
جارٍ التسجيلالمرحلة 1
- USC/Norris Comprehensive Cancer Center, Los Angeles
Longitudinal Advanced Prostate Cancer Cohort (LAPCC)
جارٍ التسجيلدراسة رصدية
- Los Angeles General Medical Center, Los Angeles
- USC / Norris Comprehensive Cancer Center, Los Angeles
MRI-Based Machine Learning Approach Versus Radiologist MRI Reading for the Detection of Prostate Cancer, The PRIMER Trial
جارٍ التسجيل
- USC / Norris Comprehensive Cancer Center, Los Angeles
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
جارٍ التسجيلالمرحلة 1
- University of Southern California, Los Angeles
- Cedars-Sanai Medical Center - Samuel Oschin Comprehensive Cancer, Los Angeles
- Cedars-Sanai Medical Center, Los Angeles
Study of Oral MRT-2359 With Apalutamide in Prostate Cancer
جارٍ التسجيلالمرحلة 2
- START Los Angeles, Los Angeles
Prostate Cancer Postoperative Stereotactic Body Radiotherapy With Adaptive Technology for Minimizing Toxicity
جارٍ التسجيلدراسة رصدية
- University of California at Los Angeles, Los Angeles
High Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for the Treatment of Prostate Adenocarcinoma
جارٍ التسجيل
- University of California at Los Angeles / Jonsson Comprehensive Cancer Center, Los Angeles
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
جارٍ التسجيلالمرحلة 3
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
FOG-001 in Locally Advanced or Metastatic Solid Tumors
جارٍ التسجيلالمرحلة 1/2
- University of California, Los Angeles (UCLA), Los Angeles
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
جارٍ التسجيلالمرحلة 2
- VA Greater Los Angeles Healthcare System, Los Angeles
- UCLA Clark Urology Center, Los Angeles
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
جارٍ التسجيلالمرحلة 1
- USC Norris Comprehensive Cancer Center, Los Angeles
- UCLA Department of Medicine, Los Angeles
NLP-Based Feedback to Improve Risk Comms and Informed Shared Decision Making
جارٍ التسجيل
- Cedars-Sinai Medical Center, Los Angeles
WALNUTS for POWER: Polyphenols, Omega-3 Fatty Acids, Weight Loss, and EneRgy
جارٍ التسجيلالمرحلة 2
- Cedars-Sinai Medical Center, Los Angeles
A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer
جارٍ التسجيلالمرحلة 2
- University of California, Los Angeles (Data and Specimen Analysis Only), Los Angeles
PSMA PET Combined With MRI for the Detection of PCa
جارٍ التسجيلالمرحلة 3مرحباً بالمتطوعين الأصحاء
- University of California Los Angeles, Los Angeles
99mTc-PSMA-I&S Biodistribution in Patients With Prostate Cancer
جارٍ التسجيلالمرحلة الأولى المبكرة
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Hormone Therapy (Apalutamide) and Image-guided Stereotactic Body Radiation Therapy for the Treatment of Patients With Prostate Cancer, HEATWAVE Trial
جارٍ التسجيلالمرحلة 2
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells
جارٍ التسجيلالمرحلة 2
- Los Angeles General Medical Center, Los Angeles
- USC / Norris Comprehensive Cancer Center, Los Angeles
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
جارٍ التسجيلالمرحلة 3
- Kaiser Permanente Los Angeles Medical Center, Los Angeles
- Los Angeles General Medical Center, Los Angeles
- USC / Norris Comprehensive Cancer Center, Los Angeles
- و 2 أخرى
Integrating Quantitative MRI and Artificial Intelligence to Improve Prostate Cancer Classification
جارٍ التسجيلدراسة رصدية
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
جارٍ التسجيلالمرحلة 2
- VA Greater Los Angeles Healthcare System, Los Angeles
Image-Guided Biopsies to Identify Mechanisms of Resistance in Patients With Metastatic Castration Resistant Prostate Cancer Treated With 177Lu-PSMA Radioligand Therapy
جارٍ التسجيلالمرحلة 1
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
جارٍ التسجيلالمرحلة 1
- Start Lacn, Los Angeles
Golf Recreational Exercise for Enhanced Survivorship in Prostate Cancer Survivors
جارٍ التسجيل
- Los Angeles General Medical Center, Los Angeles
- USC / Norris Comprehensive Cancer Center, Los Angeles
Active Surveillance for Cancer of the Prostate (ASCaP)
جارٍ التسجيلدراسة رصدية
- University of California Los Angeles, Los Angeles
Focal Radiation Therapy (HDR-Brachytherapy) for the Treatment of Prostate Cancer
جارٍ التسجيل
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Evaluation of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Active Surveillance for Prostate CancEr
جارٍ التسجيل
- UCLA, Los Angeles
HIFU for Focal Ablation of Prostate Tissue: An Observational Study
جارٍ التسجيلدراسة رصدية
- University of California, Los Angeles, Los Angeles
Green Tea and Quercetin in Combination With Docetaxel Chemotherapy in Castration-resistant Prostate Cancer Patients
جارٍ التسجيلالمرحلة 1/2
- Charles R. Drew University of Medicine and Science, Los Angeles
Mechanisms of Resistance to PSMA Radioligand Therapy
جارٍ التسجيلدراسة رصدية
- University of California, Los Angeles, Los Angeles
Access to Genetic Testing in Underserved Patients With Cancer
جارٍ التسجيلمرحباً بالمتطوعين الأصحاء
- USC / Norris Comprehensive Cancer Center, Los Angeles
Re-treatment With 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer, RE-LuPSMA Trial
جارٍ التسجيلالمرحلة 2
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Intensive Cholesterol-Lowering and CD8+ T Cells in Prostate Cancer
جارٍ التسجيلالمرحلة 2
- Cedars-Sinai Medical Center, Los Angeles
Comparing a New PSMA Imaging Agent to MRI for Detecting Prostate Cancer, BEACON Trial
جارٍ التسجيلالمرحلة الأولى المبكرة
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Phase 2 Randomized Trial of Flexible Dosing Schedule of 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT)
جارٍ التسجيلالمرحلة 2
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
جارٍ التسجيلالمرحلة 1
- USC - Norris Comprehensive Cancer Center, Los Angeles
Image-Guidance and Online Adaptation With Stereotactic Body Radiation Therapy for the Treatment of Localized Prostate Cancer, MANTICORE Trial
جارٍ التسجيل
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Vascular Optimized Radiotherapy Tuned to Critical Structures for Erectile Function Using High-Precision X-Ray Treatment
جارٍ التسجيلالمرحلة 3
- University of California at Los Angeles, Los Angeles
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
جارٍ التسجيلالمرحلة 1/2
- University of Southern California, Los Angeles
RCT of NLP-Based Feedback for Improving SDM in Men With Localized Prostate Cancer
جارٍ التسجيل
- Cedars Sinai Medical Center, Los Angeles
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
جارٍ التسجيلالمرحلة 1/2
- Research Site 125, Los Angeles
- Research Site 133, Los Angeles
- Research Site 103, Los Angeles
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
جارٍ التسجيلالمرحلة 3
- Los Angeles County-USC Medical Center, Los Angeles
- USC / Norris Comprehensive Cancer Center, Los Angeles
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
جارٍ التسجيلالمرحلة 1/2
- University of California, Los Angles (UCLA) Department of Medicine - Hematology/Oncology, Los Angeles
18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer
جارٍ التسجيلالمرحلة 4
- VA Greater Los Angeles Healthcare System, Los Angeles
تجارب سرطان البروستاتا في مدن أخرى
- New York City, NY103 دراسات
- Houston, TX76 دراسات
- Boston, MA59 دراسات
- St. Louis, MO46 دراسات
- Chicago, IL45 دراسات
- San Francisco, CA45 دراسات
- Philadelphia, PA44 دراسات
- Baltimore, MD43 دراسات
- Nashville, TN43 دراسات
- Seattle, WA42 دراسات
- Washington, DC38 دراسات
- Dallas, TX36 دراسات
دراسات أخرى في Los Angeles
- سرطان الرئة غير صغير الخلايا87 دراسات
- السرطان (جميع الأنواع)74 دراسات
- سرطان الثدي73 دراسات
- سرطان القولون والمستقيم59 دراسات
- السرطان النقيلي57 دراسات
- سرطان المبيض50 دراسات
- سرطان الرئة45 دراسات
- سرطان الخلايا الحرشفية في الرأس والرقبة42 دراسات
- سرطان البنكرياس35 دراسات
- سرطان بطانة الرحم34 دراسات
- ميلانوما34 دراسات
- سرطان الثدي الثلاثي السلبي27 دراسات
من ClinicalTrials.gov، البيانات مستخرجة في 06/10/2026. كل دراسة تحدد معايير أهليتها الخاصة؛ فريق الدراسة هو من يحدد من يمكنه المشاركة.